中文
English
Deutsch
Русский
日本語
400-029-0925
400-029-0925Tiit Mathiesen教授（瑞典）
腦膜瘤、海綿狀血管瘤、第三腦室病變、顱底和血管手術、個體化和組合式顯微放射外科手術。
Tiit Mathiesen教授在多家知名醫(yī)學雜志上發(fā)表了逾130篇論文，應邀或以訪問教授身份參加了110余場國際會議。從2015年至今，Tiit Mathiesen教授是歐洲神經(jīng)外科協(xié)會會（EANS）官方雜志Acta Neurochirurgica的主編。2003年Tiit Mathiesen教授任卡羅林斯卡學院顱底手術與良性腫瘤主管部門主任。2006-2016年任卡羅林斯卡學院神經(jīng)外科學教授。2009-2016年世界神經(jīng)外科聯(lián)合會顱底手術教育中心/卡羅林斯卡學院主任。Tiit Mathiesen自2017年至今在丹麥哥本哈根大學和Righshospitalet神經(jīng)外科擔任臨床教授和神經(jīng)外科顧問。
Tiit Mathiesen教授擁有在病毒學和免疫學方面的研究背景，并且還研究了腦外傷中的炎癥反應。他還負責主要的臨床手術。此外，Tiit Mathiesen還制作了理論教材，實踐教學課程以及舉辦有關道德和神經(jīng)外科專題的國際講座和課程。多年來，Tiit Mathiesen主要研究位于顱底的腦膜瘤以及神經(jīng)血管手術和腦室內(nèi)手術，并對腦血管和腦室內(nèi)腫瘤進行手術。位于Rigshospitalet的Neurocentret的神經(jīng)外科診所在高度專業(yè)化的水平上進行大腦和神經(jīng)手術。每年進行超過3,600次神經(jīng)外科手術，而在神經(jīng)外科門診中心，每年約有10,000次門診咨詢。 “神經(jīng)外科診所是一個非常有趣的地方，我看到有充分的機會為該部門的強勢地位的進一步發(fā)展作出貢獻，并在研究，周圍社區(qū)和患者治療之間建立聯(lián)系。我的經(jīng)驗和網(wǎng)絡很好地融入了學術和臨床結構。我期待著為國際研究和有才華的畢業(yè)生和博士的教育做出貢獻，“Tiit Mathiesen表示。
Tiit Mathiesen教授作為INC國際神經(jīng)外科醫(yī)生集團旗下組織世界神經(jīng)外科顧問團(WANG)成員，于2018年11月24日參加2018年世界神經(jīng)外科顧問團年度峰會。為與會者獻上一場場內(nèi)容豐富的神經(jīng)學科學術盛宴，分享世界領先的診療策略和手術技術。會上，Tiit Mathiesen教授帶來了《腦膜瘤的治療》的主題演講。
1. Parental age and risk of genetic syndromes predisposing to nervous system tumors: nested case-control study.
2. Hyperbaric Oxygen Therapy as Adjuvant Treatment for Hardware-Related Infections in Neuromodulation.
3. Intracranial hemorrhage due to intracranial hypertension caused by the superior vena cava syndrome.
4. An audit of immunohistochemical marker patterns in meningioma.
5. Posterior canal dehiscence syndrome caused by an apex cholesteatoma.
6. Preservation of tap vestibular evoked myogenic potentials despite resection of the inferior vestibular nerve.
7. Ethical difficulties in the innovative surgical treatment of patients with recurrent glioblastoma multiforme.
8. Ethical clinical translation of stem cell interventions for neurologic disease.
9. Combination of microsurgery and Gamma Knife surgery for the treatment of intracranial chondrosarcomas.
10. Nitric oxide synthase expression after human brain contusion.
11. Venous complications in supracerebellar infratentorial approach.
12. Socioeconomic position and the risk of brain tumour: a Swedish national population-based cohort study.
13. Hyperbaric oxygen treatment of postoperative neurosurgical infections.
14. Neurosurgery and pregnancy.
15. Population-based data: the impact on glioma treatment for elderly patients.
16. Two-year survival of low-grade and high-grade glioma patients using data from the Swedish Cancer Registry.
17. Hypoglossal schwannoma-successful reinnervation and functional recovery of the tongue following tumour removal and nerve grafting.
18. Effects of using combined transpetrosal surgical approaches to treat petroclival meningiomas.
19. Radiation-induced meningiomas: the paradox of radiation treatment.
20. Effects of using combined transpetrosal surgical approaches to treat petroclival meningiomas.
21. Potential complications following radiotherapy for meningiomas.
22. Antiepileptic drugs as prophylaxis for de novo brain tumour-related epilepsy after craniotomy: a systematic review and meta-analysis of harm and benefits.
23. Introduction. Surgery involving the venous system and complication avoidance.
24. Validation of self-reported start year of mobile phone use in a Swedish case-control study on radiofrequency fields and acoustic neuroma risk.
25. Long-term 25-year follow-up of surgically treated parasagittal meningiomas.
26. Inflammation in the brain after experimental subarachnoid hemorrhage.
27. Experimental subarachnoid hemorrhage: subarachnoid blood volume, mortality rate, neuronal death, cerebral blood flow, and perfusion pressure in three different rat models.
28. Occurrence of primary brain tumors in cochlear implant patients in Sweden between 1989 and 2014.
29. Statement of Ethics in Neurosurgery of the World Federation of Neurosurgical Societies.
30. Trigeminal complications arising after surgery of cranial base meningiomas.